Burner XT
Food supplement declared in France, declaration No 2024-1-816, decision dated 17 January 2024
Burner XT (Eiyolab) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 point in its composition requires a check (prohibited substance, dose or novel food). 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- Eiyolab
- Food business operator placing the product on the market
- LABORATOIRE TERRAVITA
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Gélule
- Daily dose
- 4 gélules
- Not recommended for (according to the manufacturer)
- Adolescents (moins de 18 ans), Femmes allaitantes, Allergie aux dérivés salicylés, Enfants (moins de 12 ans), Femmes enceintes, Problèmes cardiaques, Sous anticoagulants, Sous antidiabétiques, Sous traitement pour la thyroïde, Ulcère (estomac ou duodenum)
Declaration 138303, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- À vérifier
A product with the same brand and name was officially recalled in France (notice 2021-06-0303, published on 6 July 2021, lots bx087f): lot de coleus a fait l’objet d’une analyse révélant une non-conformité : teneur d’oxyde d’éthylène mesurée à 9,9 mg/kg, supérieure à la limite réglementaire : 0.02 mg/kg. Check your product’s batch: a recall often targets specific batches.
Source: RappelConso, French official product recalls (DGCCRF): dietary foods and food supplements, fiche 2021-06-0303.
- Conditions légales
Salix alba L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux personnes souffrant d'allergie aux dérivés salicylés.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Paullinia cupana Kunth | Graine | Extrait sec hydroalcoolique | 181 mg |
| Capsicum annuum L. | Fruit | Extrait sec hydroalcoolique | 135 mg |
| Coffea arabica L. | Graine | Extrait sec hydroalcoolique | 100 mg |
| Salix alba L. | Ecorce | Extrait sec hydroalcoolique | 100 mg |
| Withania somnifera (L.) Dunal | Racine | Extrait sec alcoolique | 100 mg |
| Panax ginseng C.A.Mey. | Racine | Extrait sec hydroalcoolique | 50 mg |
| Panax ginseng C.A.Mey. | Feuille | Extrait sec hydroalcoolique | 50 mg |
Other active ingredients
| Name | Per day |
|---|---|
| L-Carnitine L-Tartrate | not declared |
| Caféine | not declared |
| Tryptophane | not declared |
| Tyrosine | not declared |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| Picolinate de chrome | Chrome | pas de limite (données insuffisantes) | 25 µg |
Additives
E504, E471
Other ingredients
huile de tournesol, Gélule végétale
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging
Label warnings
Réservé à l'adulte. En cas de traitement médicamenteux demander l'avis d'un professionnel de la santé. Diminue l’effet des médicaments sédatifs (comme les barbituriques, les benzodiazépines, les opiacés, les anti-histaminiques de type 1). Augmente les effets indésirables des médicaments sympathomimétiques (comme l’adrénaline, la dobutamine, la dopamine, la dopexamine, l’isoprénaline, la noradrénaline, la phényléphrine)
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- BURNER XT EIYOLAB, declared in 2025 : different composition: 2 ingredient(s) added, 7 missing
- Burner XT Eiyolab, declared in 2023, withdrawal announced : different composition: 4 ingredient(s) added, 3 missing
- Burner XT Eiyolab, declared in 2021, withdrawn from the market : different composition: 8 ingredient(s) added, 6 missing
- Burner XT Eiyolab, declared in 2021, withdrawn from the market : different composition: 7 ingredient(s) added, 6 missing
Brand : Eiyolab